Siponimod vs placebo
SAEs · people with multiple sclerosis
Siponimod showed no clear difference in number of participants with at least one SAE at 6 months compared with placebo (low certainty).
1 finding from 1 review
- RR 1.8 [0.37, 8.77]2 studies · 1739 participantsLow